Aurora Spine Corp. engages in the development and distribution of spinal implant products. The company is headquartered in Toronto, Ontario. The company went IPO on 2013-09-10. The Company’s products generally fall into three product lines: interspinous process (ISP) lumbar fusion devices, Stand-alone (SA) Cervical and Lumbar fusion cages, and SI joint fusion devices. Its ISP lumbar fusion devices include the ZIP, the ZIP ULTR, the ZIP LP and the ZIP-51. The company also offers a line of interbody products: Discovery for cervical procedures; SOLO, an ALIF 3D-printed stand-alone lumbar fusion device; SiLO, a posterior allograft implant; and SiLO TFX, a titanium implant device, both for sacroiliac (SI) joint fusion, and Dexa-C a 3D printed cervical fusion device which is paired with the Apollo cervical plate. In addition, the Company markets certain third-party-developed products used during spine surgeries (i.e. surgical screws and bone growth biologic materials).
Financials in millions USD. Fiscal year is February - January.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Revenue
18
17
14
14
10
8
Revenue Growth (YoY)
13%
21%
0%
40%
25%
-27%
Cost of Revenue
7
6
6
7
5
5
Gross Profit
10
10
8
7
4
3
Selling, General & Admin
9
9
7
7
5
3
Research & Development
0
0
1
1
0
0
Operating Expenses
11
11
9
9
7
4
Other Non Operating Income (Expenses)
0
0
--
0
0
1
Pretax Income
-1
-1
-1
-1
-2
0
Income Tax Expense
--
--
--
--
--
--
Net Income
-1
-1
-1
-1
-2
0
Net Income Growth
--
0%
0%
-50%
--
-100%
Shares Outstanding (Diluted)
77.86
77.59
70.66
66.79
58.7
54.63
Shares Change (YoY)
1%
10%
6%
14%
7%
18%
EPS (Diluted)
-0.01
-0.01
-0.02
-0.02
-0.04
0
EPS Growth
107%
-46%
6%
-44%
835%
-84%
Free Cash Flow
0
0
-1
-2
-2
0
Free Cash Flow Per Share
--
--
--
--
--
--
Gross Margin
55.55%
58.82%
57.14%
50%
40%
37.5%
Operating Margin
0%
0%
-7.14%
-7.14%
-20%
-12.5%
Profit Margin
-5.55%
-5.88%
-7.14%
-7.14%
-20%
0%
Free Cash Flow Margin
0%
0%
-7.14%
-14.28%
-20%
0%
EBITDA
1
1
0
-1
-2
-1
EBITDA Margin
5.55%
5.88%
0%
-7.14%
-20%
-12.5%
D&A For EBITDA
1
1
1
0
0
0
EBIT
0
0
-1
-1
-2
-1
EBIT Margin
0%
0%
-7.14%
-7.14%
-20%
-12.5%
Effective Tax Rate
--
--
--
--
--
--
Follow-Up Questions
What are Aurora Spine Corp's key financial statements?
According to the latest financial statement (Form-10K), Aurora Spine Corp has a total asset of $11, Net loss of $-1
What are the key financial ratios for ASAPF?
Aurora Spine Corp's Current ratio is 1.57, has a Net margin is -5.88, sales per share of $0.21.
How is Aurora Spine Corp's revenue broken down by segment or geography?
Aurora Spine Corp largest revenue segment is Hospitals and Ambulatory Surgery Centers, at a revenue of 22,660,047 in the most earnings release.For geography, United States is the primary market for Aurora Spine Corp, at a revenue of 24,060,337.
Is Aurora Spine Corp profitable?
no, according to the latest financial statements, Aurora Spine Corp has a net loss of $-1
Does Aurora Spine Corp have any liabilities?
yes, Aurora Spine Corp has liability of 7
How many outstanding shares for Aurora Spine Corp?
Aurora Spine Corp has a total outstanding shares of 77.59